Physician profile
Emily Williams
NPI 1174814727
$1,008.37
in general payments reported to CMS, 2019-2025
15 companies · $374 in 2025
The $374 reported for 2025 was more than what 91% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.89 · 2021: $32.55 · 2023: $62.20 · 2024: $512 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $947.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $278.67 | 2024-2025 | Tremfya, Stelara |
| Ucb, INC. | $160.17 | 2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $120.97 | 2024 | |
| Penumbra, INC. | $119.47 | 2024 | Indigo System |
| Regeneron Healthcare Solutions, INC. | $86.09 | 2024-2025 | Dupixent, Libtayo |
| Janssen Pharmaceuticals, INC | $62.20 | 2023 | Xarelto |
| Abiomed | $32.94 | 2025 | |
| Genzyme Corporation | $29.45 | 2024 | |
| Arcutis Biotherapeutics, INC. | $29.14 | 2025 | Zoryve |
| Ultragenyx Pharmaceutical INC. | $16.40 | 2021 | |
| Abbvie INC. | $16.15 | 2021 | |
| Organon LLC | $15.57 | 2025 | Vtama |
| Portola Pharmaceuticals, LLC | $14.41 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.48 | 2019 | |
| Dermavant Sciences, INC. | $13.26 | 2024 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.